| 2016-10-18 06:01:57|
KOOL 06:01 10/18 10/18/16
Cesca Therapeutics granted third patent related for ischemic treatment
Cesca Therapeutics announced that the United States Patent & Trademark Office, or USPTO, has granted the Company the third of a family of patent applications related to its proprietary methods for the treatment of ischemic cardiovascular disorders, such as critical limb ischemia and acute myocardial infarction. The patent (numbered 9,439,930) protects key components of Cesca's SurgWerks technology platform, relating to cell compositions & methods, designed for the rapid delivery of autologous regenerative cell therapies in a point-of-care environment.